ALNYLAM PHARMACEUTICALS INC (ALNY)

Overview Price 13.05 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $13.06 Previous Close $13.05 Daily Range $12.57 - $13.11 52-Week Range $5.88 - $13.25 Volume 342,524 Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec. Other Resources for ALNY Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Alnylam Gets New Patent February 1, 2012 Zacks Blog: Alnylam to Cut 33% Jobs January 23, 2012 Zacks Blog: Alnylam Down to Neutral January 20, 2012 Zacks Blog: Alnylam States Preclinical Data December 30, 2011 Zacks Blog: Still Bullish on Alnylam December 7, 2011 Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec.   Brokerage Analyst Recommendations 7 Brokerage Firms Covering ALNY   Strong Buy 5 Buy 1 Hold 1 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.43   ALNY Ratings: BUY  SELL  HOLD ALNY Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 19 Buy 0 Sell   Top Buy Analysis BUY: ALNY Company: ALNYLAM PHARMACEUTICALS INC. Points: 57.22 Start Price: $7.76 Start Date: 12/15/2011 4:54 PM Yade P&P Score: 99.88 Recs: eaw5nh Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	02/01/12	Alnylam Gets New Patent - Analyst Blog	0
Zacks_Analysts	0.00	01/23/12	Alnylam to Cut 33% Jobs - Analyst Blog	0
Zacks_Analysts	0.00	01/20/12	Alnylam Down to Neutral - Analyst Blog	0
Zacks_Analysts	0.00	12/30/11	Alnylam States Preclinical Data - Analyst Blog	0
Zacks_Analysts	0.00	12/07/11	Still Bullish on Alnylam - Analyst Blog	0
Zacks_Analysts	0.00	12/01/11	Alnylam Completes Trial Enrollment - Analyst Blog	0
Zacks_Analysts	0.00	11/25/11	Alnylam Reveals ALNTTR01 Trial Data - Analyst Blog	0
Zacks_Analysts	0.00	11/10/11	Wider Loss at Isis Pharma - Analyst Blog	0
Zacks_Analysts	0.00	11/02/11	Alnylam Loss Tapers, Inks GSK Deal - Analyst Blog	0
Zacks_Analysts	0.00	10/11/11	Pipeline Progress at Alnylam (revised) - Analyst Blog	0

Pages: [ 1 ]  2   3   4   5  >>

Commentary

BUY: ALNYLAM PHARMACEUTICALS INC. (ALNY) Start Price: $7.76 Points: +57.22 Created: 12/15/2011 eaw5nh Comments: 0 | Comment Yade Recs:

BUY: ALNYLAM PHARMACEUTICALS INC. (ALNY) Start Price: $21.12 Points: -87.06 Created: 05/12/2009 05/12/09 05/13/09 1 day $21.30 $20.83 -2.20% Comments: 0 | Comment supratrade1 Recs:

BUY: ALNYLAM PHARMACEUTICALS INC. (ALNY) Start Price: $20.39 Points: -112.76 Created: 02/25/2009 Recommended by Zacks Comments: 0 | Comment JDShots Recs:

BUY: ALNYLAM PHARMACEUTICALS INC. (ALNY) Start Price: $22.03 Points: -32.89 Created: 01/01/2008 Comments: 0 | Comment Dante Recs:

BUY: ALNYLAM PHARMACEUTICALS INC. (ALNY) Start Price: $19.09 Points: -23.77 Created: 01/01/2008 Comments: 0 | Comment JoePass Recs:

BUY: ALNYLAM PHARMACEUTICALS INC. (ALNY) Start Price: $13.94 Points: +1.47 Created: 01/01/2008 Comments: 0 | Comment Diverstrategy Recs:

BUY: ALNYLAM PHARMACEUTICALS INC. (ALNY) Start Price: $21.54 Points: -31.54 Created: 01/01/2008 Comments: 0 | Comment kwlam Recs:

BUY: ALNYLAM PHARMACEUTICALS INC. (ALNY) Start Price: $19.00 Points: -23.45 Created: 01/01/2008 Comments: 0 | Comment RichD Recs:

BUY: ALNYLAM PHARMACEUTICALS INC. (ALNY) Start Price: $17.26 Points: -16.53 Created: 01/01/2008 Comments: 0 | Comment redsurf77 Recs:

BUY: ALNYLAM PHARMACEUTICALS INC. (ALNY) Start Price: $16.65 Points: -13.76 Created: 01/01/2008 Comments: 0 | Comment stantheman Recs:

Pages: [ 1 ]  2  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
Yade	99.88	BUY	One to Three Years	12/15/2011	$7.76	$13.04 (-0.53%)	+68.04%	+10.82%	+57.22	view close
supratrade1	99.72	BUY	One to Three Months	05/12/2009	$21.12	$13.04 (-0.53%)	-38.26%	+48.81%	-87.06	view close
JDShots	0.22	BUY	Week or Less	02/25/2009	$20.39	$13.04 (-0.53%)	-36.05%	+76.71%	-112.76	view close
Dante	72.43	BUY	Six Months to a Year	01/01/2008	$22.03	$13.04 (-0.53%)	-40.81%	-7.92%	-32.89
JoePass	31.45	BUY	Six Months to a Year	01/01/2008	$19.09	$13.04 (-0.53%)	-31.69%	-7.92%	-23.77
Diverstrategy	53.45	BUY	Six Months to a Year	01/01/2008	$13.94	$13.04 (-0.53%)	-6.46%	-7.92%	+1.47
kwlam	46.54	BUY	Six Months to a Year	01/01/2008	$21.54	$13.04 (-0.53%)	-39.46%	-7.92%	-31.54
RichD	54.63	BUY	Six Months to a Year	01/01/2008	$19.00	$13.04 (-0.53%)	-31.37%	-7.92%	-23.45
redsurf77	57.55	BUY	Six Months to a Year	01/01/2008	$17.26	$13.04 (-0.53%)	-24.45%	-7.92%	-16.53
stantheman	40.97	BUY	Six Months to a Year	01/01/2008	$16.65	$13.04 (-0.53%)	-21.68%	-7.92%	-13.76

Pages: [ 1 ]  2  >>